Product
FOL100
1 clinical trial
1 indication
Indication
Androgenic AlopeciaClinical trial
A Phase-I, Open Label, Multi-Centre Clinical Study to Assess the Safety, Tolerability and Usability of FOL100 Lotion in Comparison to Oral Finasteride, for the Treatment of Androgenetic AlopeciaStatus: Recruiting, Estimated PCD: 2024-12-01